| Product Code: ETC10600571 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Zimbabwe Human Immunodeficiency Virus Type Market Overview |
3.1 Zimbabwe Country Macro Economic Indicators |
3.2 Zimbabwe Human Immunodeficiency Virus Type Market Revenues & Volume, 2021 & 2031F |
3.3 Zimbabwe Human Immunodeficiency Virus Type Market - Industry Life Cycle |
3.4 Zimbabwe Human Immunodeficiency Virus Type Market - Porter's Five Forces |
3.5 Zimbabwe Human Immunodeficiency Virus Type Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 Zimbabwe Human Immunodeficiency Virus Type Market Revenues & Volume Share, By Medication Class, 2021 & 2031F |
3.7 Zimbabwe Human Immunodeficiency Virus Type Market Revenues & Volume Share, By Delivery Method, 2021 & 2031F |
3.8 Zimbabwe Human Immunodeficiency Virus Type Market Revenues & Volume Share, By Patient Group, 2021 & 2031F |
3.9 Zimbabwe Human Immunodeficiency Virus Type Market Revenues & Volume Share, By Treatment Goals, 2021 & 2031F |
4 Zimbabwe Human Immunodeficiency Virus Type Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and education about HIV prevention and treatment in Zimbabwe |
4.2.2 Government initiatives and funding to combat HIV/AIDS |
4.2.3 Technological advancements in HIV testing and treatment |
4.3 Market Restraints |
4.3.1 Stigma and discrimination associated with HIV/AIDS in Zimbabwe |
4.3.2 Limited access to healthcare services in rural areas |
4.3.3 High prevalence of poverty and unemployment affecting healthcare seeking behavior |
5 Zimbabwe Human Immunodeficiency Virus Type Market Trends |
6 Zimbabwe Human Immunodeficiency Virus Type Market, By Types |
6.1 Zimbabwe Human Immunodeficiency Virus Type Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 Zimbabwe Human Immunodeficiency Virus Type Market Revenues & Volume, By Treatment Type, 2021 - 2031F |
6.1.3 Zimbabwe Human Immunodeficiency Virus Type Market Revenues & Volume, By Antiretroviral Therapy, 2021 - 2031F |
6.1.4 Zimbabwe Human Immunodeficiency Virus Type Market Revenues & Volume, By Pre-exposure Prophylaxis, 2021 - 2031F |
6.1.5 Zimbabwe Human Immunodeficiency Virus Type Market Revenues & Volume, By Post-exposure Prophylaxis, 2021 - 2031F |
6.1.6 Zimbabwe Human Immunodeficiency Virus Type Market Revenues & Volume, By Adjuvant Therapy, 2021 - 2031F |
6.2 Zimbabwe Human Immunodeficiency Virus Type Market, By Medication Class |
6.2.1 Overview and Analysis |
6.2.2 Zimbabwe Human Immunodeficiency Virus Type Market Revenues & Volume, By Nucleoside Reverse Transcriptase Inhibitors, 2021 - 2031F |
6.2.3 Zimbabwe Human Immunodeficiency Virus Type Market Revenues & Volume, By Integrase Strand Transfer Inhibitors, 2021 - 2031F |
6.2.4 Zimbabwe Human Immunodeficiency Virus Type Market Revenues & Volume, By Protease Inhibitors, 2021 - 2031F |
6.2.5 Zimbabwe Human Immunodeficiency Virus Type Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.3 Zimbabwe Human Immunodeficiency Virus Type Market, By Delivery Method |
6.3.1 Overview and Analysis |
6.3.2 Zimbabwe Human Immunodeficiency Virus Type Market Revenues & Volume, By Oral, 2021 - 2031F |
6.3.3 Zimbabwe Human Immunodeficiency Virus Type Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3.4 Zimbabwe Human Immunodeficiency Virus Type Market Revenues & Volume, By Oral, 2021 - 2031F |
6.3.5 Zimbabwe Human Immunodeficiency Virus Type Market Revenues & Volume, By Injectable/Oral, 2021 - 2031F |
6.4 Zimbabwe Human Immunodeficiency Virus Type Market, By Patient Group |
6.4.1 Overview and Analysis |
6.4.2 Zimbabwe Human Immunodeficiency Virus Type Market Revenues & Volume, By HIV-Positive Adults, 2021 - 2031F |
6.4.3 Zimbabwe Human Immunodeficiency Virus Type Market Revenues & Volume, By High-Risk Populations, 2021 - 2031F |
6.4.4 Zimbabwe Human Immunodeficiency Virus Type Market Revenues & Volume, By Healthcare Workers, 2021 - 2031F |
6.4.5 Zimbabwe Human Immunodeficiency Virus Type Market Revenues & Volume, By Pregnant Women, 2021 - 2031F |
6.5 Zimbabwe Human Immunodeficiency Virus Type Market, By Treatment Goals |
6.5.1 Overview and Analysis |
6.5.2 Zimbabwe Human Immunodeficiency Virus Type Market Revenues & Volume, By Viral Suppression, 2021 - 2031F |
6.5.3 Zimbabwe Human Immunodeficiency Virus Type Market Revenues & Volume, By HIV Prevention, 2021 - 2031F |
6.5.4 Zimbabwe Human Immunodeficiency Virus Type Market Revenues & Volume, By Post-Exposure Prevention, 2021 - 2031F |
6.5.5 Zimbabwe Human Immunodeficiency Virus Type Market Revenues & Volume, By HIV-1 Transmission Prevention, 2021 - 2031F |
7 Zimbabwe Human Immunodeficiency Virus Type Market Import-Export Trade Statistics |
7.1 Zimbabwe Human Immunodeficiency Virus Type Market Export to Major Countries |
7.2 Zimbabwe Human Immunodeficiency Virus Type Market Imports from Major Countries |
8 Zimbabwe Human Immunodeficiency Virus Type Market Key Performance Indicators |
8.1 Percentage increase in the number of individuals tested for HIV annually |
8.2 Adoption rate of new HIV testing and treatment technologies in Zimbabwe |
8.3 Number of individuals receiving continuous HIV treatment and care |
8.4 HIV transmission rate within specific age groups in Zimbabwe |
8.5 Percentage of HIV-positive individuals achieving viral suppression through treatment |
9 Zimbabwe Human Immunodeficiency Virus Type Market - Opportunity Assessment |
9.1 Zimbabwe Human Immunodeficiency Virus Type Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 Zimbabwe Human Immunodeficiency Virus Type Market Opportunity Assessment, By Medication Class, 2021 & 2031F |
9.3 Zimbabwe Human Immunodeficiency Virus Type Market Opportunity Assessment, By Delivery Method, 2021 & 2031F |
9.4 Zimbabwe Human Immunodeficiency Virus Type Market Opportunity Assessment, By Patient Group, 2021 & 2031F |
9.5 Zimbabwe Human Immunodeficiency Virus Type Market Opportunity Assessment, By Treatment Goals, 2021 & 2031F |
10 Zimbabwe Human Immunodeficiency Virus Type Market - Competitive Landscape |
10.1 Zimbabwe Human Immunodeficiency Virus Type Market Revenue Share, By Companies, 2024 |
10.2 Zimbabwe Human Immunodeficiency Virus Type Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here